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Abstract
Public acceptance is critical for sharing of genomic data at scale. This paper examines how acceptance of data sharing
pertains to the perceived similarities and differences between DNA and other forms of personal data. It explores the
perceptions of representative publics from the USA, Canada, the UK and Australia (n= 8967) towards the donation of DNA
and health data. Fifty-two percent of this public held ‘exceptionalist’ views about genetics (i.e., believed DNA is different or
‘special’ compared to other types of medical information). This group was more likely to be familiar with or have had
personal experience with genomics and to perceive DNA information as having personal as well as clinical and scientiﬁc
value. Those with personal experience with genetics and genetic exceptionalist views were nearly six times more likely to be
willing to donate their anonymous DNA and medical information for research than other respondents. Perceived harms from
re-identiﬁcation did not appear to dissuade publics from being willing to participate in research. The interplay between
exceptionalist views about genetics and the personal, scientiﬁc and clinical value attributed to data would be a valuable focus
for future research.
Introduction
Genomic medicine is being integrated into healthcare in
many countries as an emerging basis of clinical care, public
health and disease prediction [1]. The collection and sharing
of genomic data is fundamental to this goal, driving
research and clinical applications, underpinning the ability
to do accurate variant interpretation [2]. Researchers have
called for global genomic data sharing, enabling databases
to be connected internationally across geographical, legal
and policy borders, for databases to be more easily acces-
sible and to ensure that they better represent the populations
having genomic testing [1, 3, 4]. The collection of genomic
information at scale is thus increasing, and major projects
are underway to link genetic and health data of millions of
citizens [1, 5].
Data sharing presents a number of challenges, notably
related to data conﬁdentiality, risk of discrimination, and the
need for appropriate governance structures [6]. However,
one important consideration in discussions of data sharing
pertains to the perceived similarities and differences
between DNA and other forms of personal data. In this
paper, we consider the relationship between perceptions of
‘genetic exceptionalism’ and the willingness to donate and
share DNA information.
The concept of ‘genetic exceptionalism’ suggests that
genetic information has different properties than other types
of medical information, i.e., it is ‘special’ because it is
uniquely identifying, directly links us to our relatives or can
provide information about our past, present and future
health [7]. Such considerations have been emphasised by
some commentators and inform policy such as the USA’s
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Genetic Information Nondiscrimination Act, which regards
genetic data as unique and meriting increased protection
[7, 8]. Others contend that features of genetic information
are shared with characteristics such as socio-economic sta-
tus, HIV status or family history [9]. They suggest that
DNA can be seen as distinct and as warranting a special
respect for privacy, without legal or regulatory protection
beyond that accorded to other sensitive information [10].
Genomic and health data come from health services,
biobanks, research projects and donated blood [11, 12].
They originate from individuals who have a right to have a
say in how this data will be used; at the very least, they
should have consented for their de-identiﬁed data to be
shared with researchers and clinicians [13]. Furthermore,
even if an individual has not yet encountered an opportunity
to donate their data they are increasingly likely to be
genetically related to someone who has. The decisions that
one person makes thus have the potential to be relevant to
relatives. To protect the rights of patients and research
participants and to respect their expectations and values
related to data use, it is important to incorporate the views
of broader publics as stakeholders in decision making. It is
thus timely to explore global public perceptions of issues
surrounding the use of de-identiﬁed DNA information
within the contexts of genomic research and clinical prac-
tice [14].
Our research examined whether ‘genetic exceptional-
ism’, deﬁned as the belief that DNA information is different
from other forms of medical information, is associated with
the willingness or unwillingness to donate data. We further
examined whether it is associated with different perceptions
of potential harms arising from sharing DNA information.
Research has identiﬁed the importance of concerns about
discrimination and the privacy of DNA information in
shaping decisions about research participation [15–17].
What has yet to be studied is the extent to which willingness
to donate and share DNA information and perception of
harms among the general public is shaped by ‘exception-
alist’ perceptions of genetic information. While exception-
alism might increase concerns about privacy, it also
suggests the potentially distinctive value of genetic
information.
In this paper, we describe the perceptions of English-
speaking respondents from the UK, USA, Australia and
Canada to the ‘Your DNA, Your Say’ (YDYS) study.
YDYS aims to examine public perceptions of genomic data
sharing across international and language borders and
involve, where practically possible, representative samples
of publics. Although important empirical work has already
been conducted in this space, particularly in the context of
biobanking, there remains limited published literature on
global public attitudes towards personal donation of DNA
information [16, 18]. The survey is a global project that has
been translated into multiple languages. Once global
recruitment is complete, we will publish separately on a
between-country meta-analysis of attitudes.
Materials and methods
Details of the study design, methodology, recruitment and
data collection are published separately, as is a review of the
context and background of this project [19–21].
Sample
Using the market research company Dynata to invite public
audiences to participate, we collected surveys from publics
in the USA, Canada, UK and Australia (n= 8967). Parti-
cipants were paid a small ﬁnancial reward (<£1) for parti-
cipating. Owing to the nature of recruitment, there are no
details on non-response rate. Dynata invited represenative
public from each country to participate and we demonstrate
how these are matched in terms of age and gender.
Measures
Our cross-sectional, exploratory online survey can be
accessed at YourDNAYourSay.org. It contains 29 questions
and piloting showed it took 15–20 min to complete.
Sociodemographic information
Information about age was collected in 10-year categories
from age 16 onwards; due to the low number of responses
in younger and older age categories these were collapsed to
‘30 years and under’ and ‘60 years and older’. Whether
participants had children was determined by the question
‘Do you have children?’ Participants were asked to answer
‘Yes’ or ‘No’ and were not asked to specify whether they
were their biological children. Relationship status was col-
lected as ‘Divorced’, ‘Separated’, ‘Single’, ‘Widowed’,
‘Married/civil partnership/living together’; all categories
apart from the latter were collapsed for analyses.
We piloted how to collect ethnicity data, starting with the
categories provided in the UK Census survey and adapting
these based on feedback from pilot participants. The
resultant ethnicity question in the ﬁnal survey asked parti-
cipants to self-identify as: White; Afro-European/African
American, Black; Hispanic; South Asian, Indian, Pakistani;
East Asian Chinese, Japanese; Arabic, Central Asian; Other.
Participants could choose not to answer this question.
Owing to the low number of participants who self-identiﬁed
as a member of a group other than ‘White’ (<10% of the
sample for each country), these were collapsed into a single
‘Non-White’ category for analysis.
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Education level was categorised as ‘Tertiary’, ‘Second-
ary’, ‘Primary’ or ‘Other’ based on structured and free text
descriptions of educational qualiﬁcations and collapsed to a
binary indicator of tertiary education for multivariable
analyses. Religiosity was determined by response to the
question ‘Independent of whether you attend religious ser-
vices or not, would you say you are…?’ with options ‘A
religious person’ or ‘Not a religious person’.
Genetics experience
Genetics experience was derived from two questions: ‘Are
you familiar with DNA, genetics or genomics?’ and ‘I’m
familiar through my work, personal interests or family/
medical history’. Participants were categorised as having
‘Personal’ experience of genetics if they said they were
familiar and that familiarity was due to either having a
genetic condition in their family, or through their work
(e.g., genetic health professional or genetic researcher).
Participants without this experience were categorised as
‘Familiar’ or ‘Unfamiliar’ based on their response to the
ﬁrst question.
View of genetic information
Participants were asked if they believed DNA information
was the same as other sorts of medical information. The
question used was:
Some people think DNA information is the same as any
other medical information, like blood pressure or blood
sugar levels. Others think DNA information is special, for
example, because it tells us how we are related to other
people. What do you think?
● For me, DNA information is different to other medical
information.
● For me, DNA information is the same as other medical
information.
● I’m not sure.
Those who answered that DNA information was differ-
ent were categorised as having ‘genetic exceptionalist
views’. As we were primarily interested in people who had
clear exceptionalist views, responses indicating that the
participant was unsure or did not think DNA information is
the same were combined.
Potential for harm
Participants were asked a single question regarding harms
associated with linking personally identifying information
to their DNA data: ‘If someone linked your name, address
and phone number to it, do you think you could be harmed
in any way from this?’. Response options were ‘Yes’, ‘No’,
‘I’m not sure’ with the latter two categories collapsed for
analysis. As we were primarily interested in whether people
had a clear understanding of the harms, the ‘No’ and
‘Unsure’ categories were collapsed for analysis.
Concerns about speciﬁc harms
Participants were presented with a list of theoretical harms
that could occur in relation to DNA information and asked
to indicate which were the three that concerned them most.
The list of theoretical harms presented to participants was:
● My friends potentially knowing something about me
that I hadn’t chosen to tell them.
● My family potentially knowing something about me that
I hadn’t chosen to tell them.
● My government potentially knowing something about
me that I hadn’t chosen to tell them.
● Police potentially knowing something about me that I
hadn’t chosen to tell them.
● Marketing companies targeting me to sell me products
● Being stigmatised and labelled in some way online.
● Being cloned.
● My DNA being copied and then planted at the scene of
a crime.
● Health or life insurance companies using the information
to discriminate against me.
● Employers using the information to discriminate
against me.
● Upsetting my genetic relatives.
● Ethnic identiﬁcation and racial discrimination.
Donating DNA and medical information
Throughout the survey, participants were asked whether
they would donate their ‘anonymous’ DNA and medical
information for use by others in research [1]1. Participants
were asked whether they would donate DNA and medical
information for use by (a) medical doctors; (b) non-proﬁt
researchers; (c) for-proﬁt researchers. Participants were
1 Within the survey glossary we explained ‘anonymous’ in more
detail: ‘Anonymous: removal of personal information such as name
and date of birth. It is questionable as to whether DNA information can
ever be truly anonymous as our DNA code is unique to us and thus, in
itself, could be used to identify us. However, in the circumstances we
are exploring here, by making DNA and medical information ‘anon-
ymous’, we mean detaching personal identiﬁers from it.’ What we are
actually meaning here is ‘de-identiﬁed’ but within the pilot work for
the survey we discovered that public participants did not naturally
understand this term and ‘anonymous’ was more easily understood,
thus we added the glossary deﬁnition within the survey itself, to
explain this in more detail.
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classiﬁed as willing to donate if they answered yes to at least
one of these questions, and as unwilling if they answered no
to all three. In terms of inﬂuences on donating, participants
were asked ‘Would being offered a DNA readout inﬂuence
your decision to donate?’ and ‘Would you be more com-
fortable donating your DNA and/or medical information if
you knew there was a law in place to protect against being
exploited?’. Finally, participants were asked ‘Would you
allow someone else, such as an ethics committee or custo-
dian, to decide on your behalf which researchers and studies
could use your DNA and/or medical information?’.
Statistical analysis
Sample characteristics were summarised using standard
descriptive statistics, with differences between those with
and without exceptionalist views evaluated using chi-
squared tests. Multivariable analyses were conducted
using multi-level binary logistic regression models to allow
for clustering of participants within countries, and estima-
tion of the variability in the outcome variables based on
country of residence. The models provide odds ratio (OR)
estimates for the association between perspective on DNA
information and either perspective on harms or willingness
to donate, holding country of residence constant [22, 23].
Multivariable analyses
The multivariable analysis investigated the association
between perceptions of DNA information and (i) percep-
tions of harms associated with linking DNA to other per-
sonal information; (ii) willingness to donate DNA for
research. Familiarity with genetics, age, gender, ethnicity,
marital status, having children, education level, and reli-
giosity have previously been associated with perceptions of
genetics and were included as covariates [24–26].
Models included a random country-level intercept to
allow for between-country variation in perspectives on harms
associated with linking DNA, and willingness to donate
DNA for research. The effect of country of residence was
quantiﬁed using the intraclass correlation and median odds
ratio [27]. Perspective on DNA information was initially
modelled as a ﬁxed effect; random slope models were then
ﬁtted to evaluate whether the associations varied by country
of residence. Familiarity with genetics, age, gender, ethni-
city, marital status, having children, education level, and
religiosity were included as ﬁxed effects. As we anticipated
that the relationship between exceptionalism and the out-
come variables would be inﬂuenced by familiarity with
genetics, an interaction term between perspective on DNA
information and familiarity with genetics was also included.
Models were ﬁtted via maximum likelihood with dif-
ference in model ﬁt evaluated using likelihood ratio chi-
squared tests and akaike information criterion (AIC) where
appropriate [28]. As the alternative hypotheses regarding
variances are technically one-sided, having the p-value for
these tests has been suggested; we report the standard p-
values but consider this modiﬁcation when interpreting
results [29]. Complete-case analyses were conducted in R
version 3.3.1 [30] using the lme4 package for multi-level
models, with 95% conﬁdence intervals (CI) for the ﬁnal
model parameter estimates obtained using bootstrapping
with 1000 replicates per model [31].
Results
Sample description
Comparison with most recent census data from each
country shows the sample is representative for gender, but
with a slight over-sampling of younger age groups and
under-sampling of those over 60 years of age (Table S1).
There was some variation between those who did and did
not have genetic exceptionalist views for all socio-
demographic variables with the exception of gender and
ethnicity (Table 1); however, there were minimal between-
country differences for this variable.
Participants with genetic exceptionalist views (~52% of
survey respondents) were more likely to report: familiarity
with genetics (35.2% versus 26.7%); personal experience
with genetics (17.2% versus 8.7%); having children (60.2%
versus 53.6%); tertiary-level education (60.5% versus
54.8%); and being religious (41.4% versus 33.1%). We
adjusted for all potential confounding effects in the multi-
variable modelling.
Associations between potential harms, willingness
to donate and genetic exceptionalism
Participants holding genetic exceptionalist views were
substantially more likely to think that linking personally
identifying information to their DNA information could
potentially harm them in some way (49.5% compared to
35.2%; see Table 2). However, concerns about speciﬁc
harms did not vary signiﬁcantly between the two groups. Of
the 11 potential harms participants were asked to rate, the
most frequently identiﬁed by both those with and without
genetic exceptionalist views was that related to ‘My DNA
being copied and then planted at the scene of a crime’
(included in the top three concerns by 45.2% of the sample).
The next most frequently identiﬁed were ‘Health or life
insurance companies using the information to discriminate
against me’ (37.2%) and ‘Marketing companies targeting
me to sell me products’ (35%) (Fig. 1 shows these results
broken down by views on genetic exceptionalism).
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Despite being more likely to identify the possibility of
harm, participants with genetic exceptionalist views were
substantially more likely to accept that their ‘anonymous’
DNA and/or medical information should be donated for
research purposes (65.3% versus 47.1%, see Table 2).
Their decision on whether to contribute their data to
research was also more likely to be inﬂuenced by the
prospect of receiving a readout of their own DNA upon
sharing their DNA (50.6% versus 30.2%) and by
knowing there are legal protections in place to prevent
exploitation (63.9% versus 47.2%). Irrespective of par-
ticipants’ view of genetic exceptionalism, only a minority
(17.4%) were comfortable with allowing a research ethics
committee to make decisions on their behalf regarding
research use of their DNA and/or medical information.
However, those who had genetic exceptionalist views
were more likely to be comfortable with this (22.7%
versus 11.7%).
Table 1 Sample characteristics by perspective on seeing DNA information as the same/unsure or different to medical information (‘genetic
exceptionalist’ views) (N indicates count; % indicates percentage)
Total
(n= 8965)
Same/unsure
(n= 4337)
Different
(n= 4628)
Variable Categories N % N % N % p
Genetics knowledge Unfamiliar 5004 55.8 2801 64.6 2203 47.6 ≪0.001
Familiar 2787 31.1 1157 26.7 1630 35.2
Personal 1173 13.1 378 8.7 795 17.2
Missing 1 0 1 0 0 0
Age 30 and under 2091 23.3 993 22.9 1098 23.7 ≪0.001
31–40 2047 22.8 959 22.1 1088 23.5
41–50 1569 17.5 823 19 746 16.1
51–60 1588 17.7 824 19 764 16.5
Over 60 1664 18.6 734 16.9 930 20.1
Missing 6 0.1 4 0.1 2 0
Gender Female 4328 48.3 2114 48.7 2214 47.8 0.255
Male 4574 51 2178 50.2 2396 51.8
Missing 63 0.7 45 1 18 0.4
Children No 3696 41.2 1925 44.4 1771 38.3 ≪0.001
Yes 5112 57 2324 53.6 2788 60.2
Missing 157 1.8 88 2 69 1.5
Education Tertiary 5173 57.7 2375 54.8 2798 60.5 ≪0.001
Secondary 3009 33.6 1520 35 1489 32.2
Primary 551 6.1 309 7.1 242 5.2
Other 224 2.5 128 3 96 2.1
Missing 8 0.1 5 0.1 3 0.1
Country United Kingdom 3316 37 1656 38.2 1660 35.9 ≪0.001
United States 1992 22.2 862 19.9 1130 24.4
Canada 2255 25.2 1112 25.6 1143 24.7
Australia 1402 15.6 707 16.3 695 15
Ethnicity White 7539 84.1 3599 83 3940 85.1 0.049
Other 1315 14.7 667 15.4 648 14
Missing 111 1.2 71 1.6 40 0.9
Religiosity Not a religious person 5609 62.6 2897 66.8 2712 58.6 ≪0.001
A religious person 3349 37.4 1435 33.1 1914 41.4
Missing 7 0.1 5 0.1 2 0
Relationship Married/civil partnership/
living together
5565 62.1 2628 60.6 2937 63.5 0.006
Divorced/Single/Widowed 3393 37.8 1704 39.3 1689 36.5
Missing 7 0.1 5 0.1 2 0
p-value shown for chi-squared test between perspectve of DNA and each variable
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Multivariable associations with perceived harm of
linking DNA information
We ﬁrst ﬁtted ‘empty’ multi-level models to investigate
how much variability in participant views of whether
linking DNA and personal information could harm them
could be explained by participant country of residence [32].
The likelihood ratio test comparing ﬁxed effects and ran-
dom intercept models indicated that there was signiﬁcant
variance explained by the between-country effect on
My DNA being copied and then planted at the scene of a crime
Health or life insurance companies using the information to discriminate against me
Marketing companies targeting me to sell me products
My government potentially knowing something about me that I hadn't chosen to tell them
Being cloned
Employers using the information to discriminate against me
Being stigmatised and labelled in some way online
My friends potentially knowing something about me that I hadn't chosen to tell them
My family potentially knowing something about me that I hadn't chosen to tell them
Police potentially knowing something about me that I hadn't chosen to tell them
Upsetting my genetic relatives (because my DNA information is similar to their DNA information)
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Fig. 1 Association between perspective on seeing DNA information as the same/unsure or different to medical information (‘genetic exceptionalist
views’) and perceived harms that could arise if a person was identiﬁed from their DNA information
Table 2 Bivariate associations between perspective on seeing DNA information as the same/unsure or different to medical information (‘genetic
exceptionalist’ views) and views on potential harms, and issues around donation of DNA for research (N indicates count; % indicates percentage)
Total Same/unsure Different
Variable Categories N % N % N % p
Harms from linking
DNA and personal info
No 5145 57.4 2808 64.7 2337 50.5 ≪0.001
Yes 3817 42.6 1526 35.2 2291 49.5
Missing 3 0 3 0.1 0 0
Would donate DNA/
medical info
No/unsure to all 3901 43.5 2294 52.9 1607 34.7 ≪0.001
Yes to all/some 5064 56.5 2043 47.1 3021 65.3
Donation inﬂuenced by
getting DNA readout
Would not donate/unsure 4136 46.1 2455 56.6 1681 36.3 ≪0.001
Donate regardless 1176 13.1 569 13.1 607 13.1
Yes 3651 40.7 1311 30.2 2340 50.6
Missing 2 0 2 0 0 0
Donation inﬂuenced by
legal protection
No/unsure 3959 44.2 2288 52.8 1671 36.1 ≪0.001
Yes 5001 55.8 2046 47.2 2955 63.9
Missing 5 0.1 3 0.1 2 0
Would allow REC to
make decisions
Would not donate/unsure 4857 54.2 2722 62.8 2135 46.1 ≪0.001
No 2545 28.4 1104 25.5 1441 31.1
Yes 1558 17.4 507 11.7 1051 22.7
Missing 5 0.1 4 0.1 1 0
p-value shown for chi-squared test between perspective of DNA and each variable (excluding missing data)
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perceived harm (χ21 = 54.3; p < 0.0001). However, the
intraclass correlations and median ORs were small; the
percentage of variance in perceived harm explained by
country of residence was only 0.8% and the median OR was
1.09.
Allowing the effect of participants’ views of the differ-
ence between DNA and other medical information to vary
by country of residence did not signiﬁcantly improve model
ﬁt (χ22 = 0.49; p= 0.78), indicating the strength of rela-
tionship between exceptionalism and perceived harm was
similar across countries. Consequently this variable was
included as a ﬁxed effect in the full multivariable model.
We tested the importance of the interaction between per-
ception of DNA information and familiarity of genetics, and
found moderate evidence to support it for this outcome
variable (χ22 = 5.64; p= 0.06; AIC 11,464 versus 11,463).
Results from the full model are shown in Table 3.
Based on the full multivariable model (Tables 3 and 4),
participants who had genetic exceptionalist views had
greater odds of thinking that linking their DNA information
to identifying personal details could potentially cause them
harm, compared to others with the same level of genetics
familiarity [OR 1.76 (95% CI: 1.56–1.98), OR 1.40
(1.19–1.65), OR 1.76 (1.35–2.31)] for ‘unfamiliar’,
‘familiar’, and ‘personal’ strata, respectively). Those who
had genetic exceptionalist views and were familiar with
genetics had greater odds of thinking this could potentially
cause them harm compared to those who did not view DNA
as different and were unfamiliar with genetics (OR 2.73,
95% CI 2.38–3.13). However, there was minimal difference
between those who were familiar with genetics and those
who had personal experience through work or a family
history of an inherited condition (OR 2.81, 95% CI
2.36–3.35 for the latter).
Table 3 Results from the multivariable multi-level model for perceived harms from linking DNA and personally identifying information, and for
willingness to donate DNA and medical information for research
Perceived harms (N= 8704) Donating for research (N= 8704)
Variable Categories Beta 95% CI p Beta 95% CI p
Fixed effects
DNA status Same as other medical
information
Ref. Ref.
Different 0.57 0.44 to 0.68 ≪0.001 0.69 0.57 to 0.8 ≪0.001
Genetics experience Unfamiliar Ref. Ref.
Familiar 0.67 0.51 to 0.81 ≪0.001 0.67 0.53 to 0.82 ≪0.001
Personal 0.47 0.22 to 0.7 ≪0.001 1.28 1.03 to 1.54 ≪0.001
Interaction Different × familiar −0.23 −0.43 to −0.02 0.022 −0.24 −0.44 to −0.05 0.016
Different × personal 0.00 −0.29 to 0.32 0.99 −0.23 −0.56 to 0.11 0.15
Age 50 and older Ref. Ref.
31−50 −0.11 −0.22 to −0.01 0.03 0.09 −0.02 to 0.2 0.07
30 and younger −0.13 −0.25 to 0.01 0.05 0.49 0.36 to 0.62 ≪0.001
Gender Female Ref. Ref.
Male 0.07 −0.01 to 0.16 0.11 0.08 0 to 0.19 0.03
Children No Ref. Ref.
Yes −0.06 −0.15 to 0.06 0.30 0.15 0.05 to 0.26 0.007
Tertiary education Yes Ref. Ref.
No −0.26 −0.34 to −0.17 ≪0.001 −0.24 −0.37 to −0.19 ≪0.001
Ethnicity White Ref. Ref.
Other 0.04 −0.09 to 0.18 0.50 −0.34 −0.47 to −0.21 ≪0.001
Religiosity Not a religious person Ref. Ref.
A religious person 0.17 0.07 to 0.26 ≪0.001 0.12 0.03 to 0.22 0.01
Relationship status Married/civil partnership/living
together
Ref. Ref.
Divorced/single/widowed 0.01 −0.11 to 0.12 0.89 −0.06 −0.16 to 0.04 0.26
Random effects
Intercept variance 0.02 0 to 0.04 0 0 to 0.003
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Multivariable associations with donating DNA
information for research
The likelihood ratio test comparing ﬁxed effects and
random intercept models did not indicate that substantial
variance was explained by the between-country effect on
willingness to donate DNA and/or medical information
for research (χ21 = 3.18; p= 0.075) and thus a standard
logistic regression model could feasibly be ﬁtted. We
retained the multi-level model speciﬁcation to ensure we
adequately accounted for between-country differences.
Allowing the effect of participant view of the difference
between DNA and other medical information to vary by
country of residence did not signiﬁcantly improve model
ﬁt (χ22 = 2.69; p= 0.26) and this was, therefore, included
as a ﬁxed effect in the full multivariable model. We
tested the interaction between willingness to donate DNA
and/or medical information and familiarity with genetics
and found evidence to support it for this outcome vari-
able (χ22 = 6.65; p= 0.036; AIC 11,171 versus 11,168).
Results are shown in Table 3.
In the full multivariable model (Tables 3 and 4),
participants who had genetic exceptionalist views had
greater odds of being willing to donate their DNA com-
pared to others with the same level of genetics familiarity
[OR 1.98 (95% CI: 1.78–2.24), OR 1.55 (1.32–1.83), OR
1.58 (1.18–2.12) for ‘unfamiliar’, ‘familiar’, and ‘per-
sonal’ strata, respectively]. Those who had personal
experience of genetics and genetic exceptionalist views
had the greatest odds of being willing to donate, com-
pared to those who were unfamiliar with genetics and did
not have a genetic exceptionalist view (OR 5.66, 95% CI
4.64–6.91). Those with personal experience of genetics
also had greater odds of being willing to donate, even if
they did not have genetic exceptionalist views (OR 3.58,
95% CI 2.81–4.65). However, those who were familiar
with genetics and had genetic exceptionalist views had
similar odds of being willing to donate (OR 3.05, 95% CI
2.66–3.49).
Discussion
In this age and gender-matched sample from the USA,
Canada, the UK and Australia, participants who held
genetic exceptionalist views were more likely to be familiar
with or have had personal experience with genomics. They
were also the most likely to say they were willing to donate
their ‘anonymous’ DNA and medical information to
research, despite also being the most likely to understand
that linking DNA information to personal information had
the potential to cause harm. Thus, while they identiﬁed the
possibility of harm if they were re-identiﬁed from their data,
they would still donate, presumably because they accepted
the beneﬁts outweighed the perceived harms. This is con-
cordant with the ﬁndings of previous research on bio-
banking and the donation of DNA information for research
[33]. In other words, those interested in data donation
appear aware of both what genetic information is and its
value for research and genomic medicine.
Participants with genetic exceptionalist views and self-
reported familiarity with genomics had the greatest odds
(nearly 6 times greater) of being willing to donate their
DNA information (compared to those who were unfamiliar
with genomics and did not have exceptionalist views). Such
willingness among those with personal familiarity has been
seen in patient groups who want their data to be put to good
use for future disease prevention, or to help future genera-
tions within their own family [34, 35]. Many of those most
willing to donate were also professionals working in the
genomics ﬁeld. This is in agreement with our previous
research on the liberal attitudes of scientists to participate in
genomic research [36].
The perceived harms that participants associated with
being identiﬁed from one’s DNA information reﬂect the
inﬂuence of popular culture. After secondary education,
most non-experts are thought to absorb science informa-
tion and knowledge from the media [37]. For example, TV
shows such as CSI (American television programme,
made 2000–2015) with 30–50 million viewers worldwide
Table 4 Odds ratios for
interaction between genetics
experience and perspective on
DNA information (‘genetic
exceptionalist’ views) for (i)
thinking that linking DNA and
personally identifying could
cause potential harm and (ii)
willingness to donate DNA for
medical research (derived from
full multivariable model)
Outcome Genetics
experience
Perspective on DNA data DNA perspective within
genetics experience
Same/unsure Different
Perceived harms Unfamiliar Ref. 1.76 (1.56 to 1.98) 1.76 (1.56 to 1.98)
Familiar 1.95 (1.67 to 2.25) 2.73 (2.38 to 3.13) 1.40 (1.19 to 1.65)
Personal 1.60 (1.25 to 2.02) 2.81 (2.36 to 3.35) 1.76 (1.35 to 2.31)
Willingness
to donate
Unfamiliar Ref. 1.98 (1.78 to 2.24) 1.98 (1.78 to 2.24)
Familiar 1.96 (1.70 to 2.28) 3.05 (2.66 to 3.49) 1.55 (1.32 to 1.83)
Personal 3.58 (2.81 to 4.65) 5.66 (4.64 to 6.91) 1.58 (1.18 to 2.12)
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function as a resource for quasi-scientiﬁc information
about genetics [38]. Media representations play an
important role in shaping public familiarity with science,
including framing or priming conversations about DNA
[39]. The identiﬁcation by participants of concerns about
their DNA being copied and then planted at the scene of a
crime ﬁts with this picture. What we are not able to
conclude is whether participants have a genuine concern
about this, or whether it is made salient and plausible by
exposure to popular media.
Risks associated with data sharing may be seen as less
concrete and more future-oriented than beneﬁts [18].
However, the relevance of perceived ‘harms’ as actual
‘risks’ needs to be understood in relation to their probability
of occurring [40]. Public engagement that discusses the
potential risks or harms of linking DNA information to
personal information, however small or unlikely, may
therefore not adversely affect the willingness of people to
donate their data. Indeed, engagement activities that explain
the distinctive features of DNA data may in fact support
engagement with research.
Those with exceptionalist views were more likely to
make decisions about donation based on whether they could
obtain a copy of their own raw data (a ‘DNA readout’ or
raw sequence data) in return and if they were aware of any
clear legal sanctions in place to protect against exploitation.
This reﬂects the perceived personal and economic, as well
as clinical and scientiﬁc, value of DNA information. This
group was more likely to allow research ethics committees
(RECs) to make decisions about data sharing on their
behalf. These ﬁndings suggest the potential value of
returning results to this population, but also the corollary,
that receiving sequence data may be less appealing to those
who do not regard it as something special or distinctive.
They also emphasise the importance of transparent pro-
cesses for decision making around data sharing, and com-
munication about the sanctions consequent upon data
misuse.
Limitations
Exploratory online surveys have important limitations in
that they capture perceptions about intended behaviour at a
single time point. While intentions are one potential pre-
dictor of behaviour, further work is needed to document
what people actually do when faced with opportunities to
donate data [41]. Generic limitations of the study and online
survey design have been published separately [19]. Our
ﬁndings should not be extrapolated to indicate views of all
people from the USA, Canada, the UK and Australia, par-
ticularly the older population who may differ in respect of
their willingness to donate and beliefs about the uniqueness
of genetic information.
Conclusion
Big data and genomics now go hand in hand, and it is time
to bring broader publics into conversation about their
willingness to donate their data to be accessed and shared to
enable the potential of genomic medicine to be fully rea-
lised. To support this, we have explored ‘representative’
English-speaking public perceptions of genomic data
donation and some of the characteristics of those reportedly
willing to donate their data for use in the research
endeavour.
There appear obvious factors that may support and
encourage data donation and sharing, such as offering to
return results in some form, providing clear information
about legal protections, and engagement that addresses the
distinctive characteristics of genetic information. The
potential of these approaches should be explored and
evaluated. However, it is not sufﬁcient to ‘educate’ people
about genomics—familiarity does not necessarily equate
factual knowledge. Rather, we must work to understand
what people need to know and how to make the subject
resonate, so that genomics becomes a social and sociable
concept and that citizens can feel comfortable having a
basic conversation about its beneﬁts and limitations.
Finally, we found that despite believing that there were
potential speciﬁc risks from re-identiﬁcation, these alone
did not appear to dissuade publics from being willing to
participate in research. Thus, for some, it appears that DNA
has sufﬁcient value to warrant donation for research.
Exploring the interplay between exceptionalist views and
the personal, scientiﬁc and clinical value attributed to data
would be a fruitful focus for future research.
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